| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 10 |
| GO:0110165 | cellular anatomical entity | 1 | 10 |
Related structures:
AlphaFold database: A4HIA8
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_PCSK_SKI1_1 | 14 | 18 | PF00082 | 0.478 |
| CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.424 |
| DEG_MDM2_SWIB_1 | 98 | 105 | PF02201 | 0.357 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.648 |
| DOC_USP7_MATH_1 | 22 | 26 | PF00917 | 0.214 |
| LIG_14-3-3_CanoR_1 | 14 | 20 | PF00244 | 0.357 |
| LIG_14-3-3_CanoR_1 | 33 | 39 | PF00244 | 0.302 |
| LIG_LIR_Nem_3 | 37 | 42 | PF02991 | 0.361 |
| LIG_Pex14_1 | 58 | 62 | PF04695 | 0.469 |
| LIG_Pex14_2 | 98 | 102 | PF04695 | 0.324 |
| LIG_SH2_CRK | 39 | 43 | PF00017 | 0.445 |
| LIG_SH2_CRK | 62 | 66 | PF00017 | 0.621 |
| LIG_SH2_STAT5 | 62 | 65 | PF00017 | 0.613 |
| LIG_SH2_STAT5 | 91 | 94 | PF00017 | 0.337 |
| LIG_SH3_3 | 101 | 107 | PF00018 | 0.439 |
| LIG_SH3_3 | 6 | 12 | PF00018 | 0.533 |
| LIG_SUMO_SIM_par_1 | 78 | 85 | PF11976 | 0.629 |
| LIG_WRC_WIRS_1 | 52 | 57 | PF05994 | 0.302 |
| MOD_CK1_1 | 18 | 24 | PF00069 | 0.412 |
| MOD_CK1_1 | 54 | 60 | PF00069 | 0.316 |
| MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.230 |
| MOD_GSK3_1 | 10 | 17 | PF00069 | 0.562 |
| MOD_GSK3_1 | 18 | 25 | PF00069 | 0.247 |
| MOD_N-GLC_1 | 5 | 10 | PF02516 | 0.515 |
| MOD_N-GLC_2 | 61 | 63 | PF02516 | 0.363 |
| MOD_NEK2_1 | 5 | 10 | PF00069 | 0.731 |
| MOD_PKA_2 | 10 | 16 | PF00069 | 0.711 |
| MOD_PKA_2 | 73 | 79 | PF00069 | 0.642 |
| MOD_Plk_1 | 5 | 11 | PF00069 | 0.533 |
| MOD_Plk_4 | 34 | 40 | PF00069 | 0.286 |
| TRG_ENDOCYTIC_2 | 39 | 42 | PF00928 | 0.448 |
| TRG_ENDOCYTIC_2 | 62 | 65 | PF00928 | 0.613 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P2Z8 | Leptomonas seymouri | 90% | 100% |
| A0A0S4JA04 | Bodo saltans | 50% | 100% |
| A0A1X0P1Y7 | Trypanosomatidae | 59% | 100% |
| A0A3Q8IE83 | Leishmania donovani | 93% | 100% |
| A0A422P4W3 | Trypanosoma rangeli | 58% | 96% |
| A4I5J2 | Leishmania infantum | 93% | 100% |
| C9ZQS7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 63% | 98% |
| E9B0T7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
| Q4Q7D9 | Leishmania major | 91% | 100% |